# Estee Lauder Invests In 111SKIN.

*business · news · 2026-04-30 · Benzinga*

## Key points

- Estee Lauder announced a minority investment in clinical skincare brand 111SKIN; terms remain undisclosed.
- 111SKIN derives 20% of its sales from direct-to-consumer channels and has a global luxury presence.
- Estee Lauder is trading 22% below its 100-day SMA, signaling continued intermediate-term weakness.
- Analyst price targets for Estee Lauder have recently been lowered, despite maintaining a Buy consensus.
- Estee Lauder has significant ETF exposure, influencing the stock during large ETF inflows or outflows.

**Companies:** Estee Lauder Companies, 111SKIN
**Countries:** United States, China, United Kingdom, France

[Read the full story on Benzinga](https://www.benzinga.com/markets/equities/26/04/52167479/estee-lauder-eyes-clinical-beauty-boom-with-111skin-deal)

---

Canonical: https://newsio.io/n/05108234-7c8a-4ceb-8999-2de939b61dfc/estee-lauder-invests-in-111skin-terms-were-not-disclosed-the-move-targets-rising
Summarized by Newsio from Benzinga. https://newsio.io/how-it-works